Baillie Gifford - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 56 filers reported holding UNITY BIOTECHNOLOGY INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2022$233,000
-29.8%
589,1110.0%0.00%
Q2 2022$332,000
-49.7%
589,1110.0%0.00%
Q1 2022$660,000
-23.3%
589,1110.0%0.00%
Q4 2021$860,000
-51.3%
589,1110.0%0.00%
-100.0%
Q3 2021$1,767,000
-83.5%
589,111
-74.4%
0.00%
-80.0%
Q2 2021$10,691,000
-53.1%
2,304,111
-39.4%
0.01%
-61.5%
Q1 2021$22,818,000
+14.5%
3,803,0140.0%0.01%
+18.2%
Q4 2020$19,928,000
+51.5%
3,803,0140.0%0.01%
+22.2%
Q3 2020$13,158,000
-60.1%
3,803,0140.0%0.01%
-64.0%
Q2 2020$33,011,000
+49.7%
3,803,0140.0%0.02%
+4.2%
Q1 2020$22,057,000
-19.6%
3,803,0140.0%0.02%
-7.7%
Q4 2019$27,420,000
+18.2%
3,803,0140.0%0.03%0.0%
Q3 2019$23,199,000
-35.8%
3,803,0140.0%0.03%
-31.6%
Q2 2019$36,129,000
+17.1%
3,803,0140.0%0.04%
+11.8%
Q1 2019$30,842,000
-50.1%
3,803,0140.0%0.03%
-57.5%
Q4 2018$61,837,000
-0.2%
3,803,0140.0%0.08%
+19.4%
Q3 2018$61,951,000
+8.2%
3,803,0140.0%0.07%
+8.1%
Q2 2018$57,274,0003,803,0140.06%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q4 2018
NameSharesValueWeighting ↓
Mayo Clinic 1,571,981$9,117,00023.05%
Invus Financial Advisors, LLC 2,189,998$12,702,0006.24%
Leap Investments LP 13,400$78,0000.11%
Moloney Securities Asset Management, LLC 51,950$301,0000.11%
Verity Asset Management, Inc. 14,748$86,0000.11%
Virtus ETF Advisers LLC 43,010$249,0000.10%
Investors Financial Group, LLC 15,850$92,0000.09%
SUNFLOWER BANK, NA WEALTH MANAGEMENT 20,000$116,0000.04%
Baillie Gifford 3,803,014$22,057,0000.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 315,047$1,827,0000.02%
View complete list of UNITY BIOTECHNOLOGY INC shareholders